RTI Biologics Inc. has agreed to buy medical technology firm Pioneer Surgical Technology for $130 million in cash as the maker of biologic implants looks to expand its current implant portfolio into metals and synthetics and to grow direct distribution.
Beringea, the private equity group, which provides equity and/or mezzanine debt to small- and-middle market companies, has exited five companies.